About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 176 record(s)
Req # A-2021-001863
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_02521787.Organization: Health Canada
May 2022
Req # A-2021-002049
Adverse Drug Reaction (ADR) for Eculizumab. Report number: E2B_04788657.Organization: Health Canada
May 2022
Req # A-2021-002055
Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B_04875745.Organization: Health Canada
May 2022
Req # A-2021-002096
Adverse Drug Reaction (ADR) for BISACODYL. Report number: E2B_04699223.Organization: Health Canada
May 2022
Req # A-2021-002101
Adverse Drug Reaction (ADR) for BISACODYL. Report number: E2B_04949285.Organization: Health Canada
May 2022
Req # A-2021-002149
Adverse Drug Reactions (ADRs) for BISACODYL. Report numbers: E2B_04825443, E2B_04699223, E2B_04892483, E2B_04949285.Organization: Health Canada
May 2022
Req # A-2022-000102
Adverse Drug Reaction (ADR) for CANCIDAS. Report number: E2B_02706392.Organization: Health Canada
May 2022
Req # A-2021-000384
Requesting the following information regarding medical device BLEScath Intratracheal Catheter (license no. 105680, device identifier 54-1100): The approved purpose/intended use of the device. The approved labelling. Published clinical literature…Organization: Health Canada
April 2022
Req # A-2021-000775
The Privacy Impact Assessment and/or the Privacy Compliance Evaluation that was performed regarding ArriveCAN mobile application pursuant to the Interim Directive on Privacy Impact Assessment from the Treasury Board.Organization: Health Canada
April 2022
Req # A-2021-001446
The complete list of medical cannabis research that Health Canada has been involved in since the enacting of the original Marihuana Medical Access Regularions (MMAR) legislation, through to November 26th, 2021.Organization: Health Canada
April 2022